RUSH: I’m sure you’ve seen the story, but you may not know all about the story here, all the details. I have two versions of this story. One is from the Los Angeles Times, and the other one is from the UK Times Online. Let me put these stories together. Both stories have to do with the same subject.
First off, the LA Times story: ‘Stem Cells Shown to Rein in Type 1 Diabetes — Researchers have demonstrated for the first time that the progression of Type 1 diabetes…’ That’s the bad kind. They’re both bad, but Type 2 is what you get from lifestyle circumstances later in life, and you can sometimes control Type 2 with diet and exercise and all that. Type 1 isn’t. If you’re going to get it, Type 2 is the one to get. You don’t want either, don’t misunderstand here, but Type 1 is the worst of the two. The researchers say that they’ve ‘demonstrated for the first time that the progression of Type 1 diabetes can be halted — and possibly reversed — by a stem-cell transplant that preserves the body’s diminishing ability to make insulin, according to a study published today. The experimental therapy eliminated the need for insulin injections for months or even years in 14 of 15 patients recently diagnosed with [Type 1 diabetes]. One subject, a 30-year-old male, hasn’t taken insulin since his stem-cell transplant more than three years ago, according to the study in the Journal of the American Medical Assn.’
Now, I read the whole story, but I’m not going to read it all to you. Let me go to the UK Times version because I’m sure you’re all wondering, ‘What kind of stem cells?’ Well, you have to read to the very end of both of these stories to find out what kind of stem cells, and I’ll give you a little hint. You will not find the word ’embryonic’ in either of these stories. ‘Some of those patients are now treated with transplants of beta cells harvested from cadavers. Scientists also are trying to use embryonic stem cells to grow beta cells for transplant…’ That has nothing to do with this story. They throw that in. No embryonic stem cells were at work here on the Type 1 diabetes research. Now, the UK Times story is basically the same thing: ‘Diabetics Cured by Stem-Cell Treatment.’ You read and you read and you read and you read, and you ask, ‘What kind of stem cells?’ and of course you know what kind of stem cells when they don’t mention what kind of stem cells because you know that the Drive-By Media worldwide has an agenda here. They’re operating under an action line or a storyline, too, and of course the purpose of leaving out what kind of stem cells is because, what kind of stem cells have the most publicity and notoriety?
It would be embryonic stem cells, and of course they figure that most people will conclude it’s embryonic if they don’t mention it. So later on in this story: ‘They enrolled Brazilian diabetics aged between 14 and 31 who had been diagnosed within the previous six weeks. After stem cells had been harvested from their blood…’ (Gasp!) Not only was it somebody else’s stem cells, and not only was it not embryonic, it was stem cells from their own bodies, 14 to 31 age-group, so you say no embryonics used here. They were mostly adult stem cells. ‘After stem cells had been harvested from their blood, they then underwent a mild form of chemotherapy to eliminate the white blood cells causing damage to the pancreas. They were then given transfusions of their own stem cells to help rebuild their immune systems.’ So, this is amazingly great news. We’re all happy about the great news here for the future implications of dealing with Type 1 diabetes, but it’s adult stem cells, folks, and I just wanted to pass that on.